Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D1R6VD
|
|||
| Drug Name |
VCTX210
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Type-1 diabetes [ICD-11: 5A10] | Phase 1 | [1] | |
| Company |
CRISPR Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05210530) An Open-Label, First-In-Human Study Evaluating the Safety and Tolerability of VCTX210A Combination Product in Subjects With Type 1 Diabetes Mellitus (T1D). U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.